New drug shows promise in clearing Heart-Clogging protein
NCT ID NCT07448623
First seen Mar 10, 2026 · Last updated Apr 30, 2026 · Updated 10 times
Summary
This study is for people with a rare heart condition called ATTR-CM, where abnormal protein builds up in the heart. Researchers are testing a new drug, coramitug, to see how well it targets and removes these protein deposits. The study uses special PET/CT scans to track the drug and measure its effects. Only 14 participants will take part, and the main goal is to understand how the drug works in the body, not yet to prove it cures the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSTHYRETIN AMYLOID CARDIOMYOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ICON - location Groningen
RECRUITINGGroningen, 9728 NZ, Netherlands
Conditions
Explore the condition pages connected to this study.